Steba Biotech

    OverviewSuggest Edit

    Steba Biotech is a company that provides therapeutic solutions for the treatment of cancers. It is engaged in research focusing on prostate cancer, oesophagus cancer, urothelial cell carcinoma, kidney cancer, triple-negative breast cancer, and pancreatic cancer. In addition, the company develops TOOKAD, a photosensitizer derived from palladium-substituted bacteriochlorophyll and used to treat prostate cancer.
    TypePrivate
    Founded1996
    HQToussus-le-Noble, FR
    Websitestebabiotech.com

    Latest Updates

    Employees (est.) (Oct 2021)29
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Steba Biotech

    Fabrice Harari

    Fabrice Harari

    CEO and Chairman

    Steba Biotech Office Locations

    Steba Biotech has offices in Toussus-le-Noble and Luxembourg
    Toussus-le-Noble, FR (HQ)
    3 Avenue de l'Europe
    Luxembourg, LU
    7 Place du Théâtre
    Show all (2)

    Steba Biotech Financials and Metrics

    Summary Metrics

    Founding Date

    1996

    Steba Biotech Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    94/100

    SecurityScorecard logo

    Steba Biotech Online and Social Media Presence

    Embed Graph

    Steba Biotech News and Updates

    Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer

    LUXEMBOURG, April 20, 2021 (GLOBE NEWSWIRE) --  Steba Biotech, the pioneering Immune Photo Activate Cancer Treatment (ImPACT) specialist, today announces the treatment of the first patient in ENLIGHTED, its pivotal Phase 3 trial of Padeliporfin ImPACT for the treatment of Low Grade Upper Tract Uro…

    Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract Urothelial Cancer

    LUXEMBOURG, March 08, 2021 (GLOBE NEWSWIRE) -- Steba Biotech, the IMmune Photo Activate Cancer Treatment (IMPACT) specialist today announces the U.S. Food and Drug Administration granted Orphan Drug Designation (ODD) to Padeliporfin ImPACT for the treatment of adult patients with Upper Tract Uroth…

    Steba Biotech Frequently Asked Questions

    • When was Steba Biotech founded?

      Steba Biotech was founded in 1996.

    • Who are Steba Biotech key executives?

      Steba Biotech's key executives are Fabrice Harari.

    • How many employees does Steba Biotech have?

      Steba Biotech has 29 employees.

    • Who are Steba Biotech competitors?

      Competitors of Steba Biotech include Nanospectra Biosciences, NeoTherma Oncology and Northwestern Medicine Proton Center.

    • Where is Steba Biotech headquarters?

      Steba Biotech headquarters is located at 3 Avenue de l'Europe, Toussus-le-Noble.

    • Where are Steba Biotech offices?

      Steba Biotech has offices in Toussus-le-Noble and Luxembourg.

    • How many offices does Steba Biotech have?

      Steba Biotech has 2 offices.